ELVN
NASDAQ · Pharmaceuticals
Enliven Therapeutics Inc
$41.26
+0.97 (+2.41%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
-23.2% upside
Low Target
$20.91
Average Target
$31.67
High Target
$36.06
Current Price
$41.26
Current
$41.26
$41.26
Target
$31.67
$31.67
$20.91
$31.67 avg
$36.06
Scenario Analysis
Bear Case
$20.91
-49.3%
Low target
Base Case
$31.67
-23.2%
Avg target
Bull Case
$36.06
+-12.6%
High target
Risk/Reward
0.3x
Unfavorable
Price in Context
52-Week High
$48.53
-15.0% from high
52-Week Low
$14.79
+179.1% from low
Target vs 52W High
$31.67
-34.7% vs high
Next Earnings Report
May 20, 2026
9d
until earnings
EPS Est: $-0.47
Earnings in 9 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals